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Abstract
Lipoid pneumonia is a rare pulmonary disease, classified in terms of the source of lipid exposure into two variants: exogenous 
and endogenous. We present a patient with exogenous lipoid pneumonia, acquired after chronic exposure to paraffin oil-conta-
ining nasal drops. The diagnosis was established by demonstration of lipid-laden macrophages in bronchoalveolar lavage, chest 
computed tomography results and a history of lipid exposure.
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Introduction
Lipoid pneumonia is an uncommon con-
dition, initially described in 1925 by Laughlen 
in autopsy series of three children and one adult 
[1, 2]. Its clinical incidence is difficult to precise, 
however, one American autopsy study has repor-
ted the frequency of 1.0–2.5% [1, 3, 4]. Exogenous 
lipoid pneumonia may occur in subjects of any 
age, however, it is more likely to affect the elderly, 
particularly those who have a history of chronic 
laxatives or nasal drop use. 
The condition results from accumulations of 
lipids in the alveoli. Various clinical manifesta-
tions have been described. In about half of the 
cases, the disease is asymptomatic, in others, it 
manifests with cough and progressive dyspnoea 
on exertion. In patients with massive aspiration 
of lipids in short time, the symptoms of severe, 
life-threatening respiratory failure requiring ven-
tilator support may develop [5]. 
 Radiological presentations are diverse, there 
is no specific, pathognomonic finding, however, 
chest computed tomography (chest CT) plays a 
complementary role in the diagnosis, which is 
often difficult [1]. Therefore, a history of expo-
sure should be investigated in details in order to 
confirm the diagnosis.
We report a case of a female patient with 
chronic exogenous lipoid pneumonia, which was 
diagnosed in the I Department of Lung Diseases, 
National Tuberculosis and Lung Diseases Rese-
arch Institute.
Case report
A 57-year-old woman, active smoker, with 
a history of 30 pack-years, was admitted to 
our clinic because of progressive dyspnoea on 
exertion and dry cough, since the beginning of 
2018. In February and August 2018, the patient 
suffered from infectious pneumonia, which has 
been successfully treated with antibiotics. Past 
medical history revealed chronic kidney disease 
(Stage G3a), diabetes mellitus type 2, arterial 
hypertension and duodenal ulcerations. Due 
to persistent opacities on the chest radiograph, 
a chest-CT has been performed, which showed 
multiple confluent areas of ground-glass opacities 
in the middle lobe, both lower lobes and areas of 
parenchymal consolidations with density similar 
to fat (between -150 and -30 Hounsfield units) in 
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segment 10 of the right lobe and basal segments 
of the left lower lobe (Figures 1 and 2).
At admission, oxygen saturation in room air 
was lowered to 88%, heart rate was 62 bpm, blood 
pressure — 135/80 mm Hg. Auscultation of the 
lungs revealed bilateral basal crepitations. The 
blood tests showed no elevation of the inflamma-
tory markers, a slightly elongated aPTT (37,5 s) 
and elevated D-dimer (1391 ng/mL) were noted. 
Antiphospholipid syndrome and other systemic 
connective tissue diseases were excluded (anti
-nuclear antibodies like anti-dsDNA, anti-SS-A, 
anti-SS-B, Anti-RNP, anti-Scl-70, anti-Jo-1, anti-
Mi-2, lupus anticoagulant and anticardiolipin 
antibodies were negative). Chest radiograph 
showed bilateral opacities, especially in the left 
supradiaphragmatic area (Figure 3). Lung func-
tion tests were normal (Table 1). The patient un-
derwent a fiberoptic bronchoscopy, which did not 
reveal any pathologies in the main or segmental 
bronchi. Cultures of bronchial washings were 
negative. Bronchoalveolar lavage (BAL) from 
the left lower lobe was performed with 60% of 
recovery. Under macroscopic evaluation, the 
fluid was described as turbid, with fat-like layer 
on the surface. Cytological examination showed 
a significant amount of foamy macrophages, pro-
bably with accumulations of lipid material (Table 
2). The specific probe staining was not performed 
due to technical reasons. 
Based on BAL result, a carefully perfor-
med anamnesis revealed an over 10 years long 
exposure to paraffin oil-containing nasal drops, 
which patient was using due to nasal blockade 
congestion. Deviated nasal septum as a cause was 
confirmed in rhinoscopy. The patient was stron-
gly advised to stop using the nasal drops. After 
three months on a control visit, clinically she was 
well, lung function test was stable, although the 
radiological changes were still remaining. 
Discussion
Lipoid pneumonia is a rare, nonspecific cause 
of inflammatory lung disease [1, 3, 4, 6].
Basing on the source of the lipids exposure, 
lipoid pneumonia has been classified into endoge-
nous and exogenous [1]. The pathogenesis of the 
endogenous form is complex, the source of lipids 
is the lung tissue itself, the disease may occur as 
a result of infection (mainly in the obstructed 
bronchus), repetitive episodes of fungal infec-
tions or due to the non-infectious process such as 
pulmonary alveolar proteinosis and lipid-storage 
disorders (Niemann-Pick disease) [1, 3, 6, 7].
Figure 1. Chest CT scan at the level of lower lobes demonstrates areas 
of parenchymal consolidations especially in the left lung
Figure 2. Chest CT scan at the level of middle lobe demonstrates areas 
of ground-glass attenuation
Figure 3. Chest radiograph shows bilateral opacities, especially in the 
left lung supradiaphragmatic area
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The exogenous type of lipoid pneumonia 
occurs as a result of exposure to various fatty 
substances (mostly mineral oils), which may be 
inhaled or ingested. This form of disease con-
cerns adults with chronic obstipation treated 
with oil-based laxatives, chronic rhinopharyngeal 
diseases treated with nasal drops, or due to aspira-
tion-related syndromes in patients with impaired 
mental status or impaired swallowing mechanism 
[5]. Rare cases of exogenous lipoid pneumonia are 
mentioned in the literature after aspiration during 
‘fire-eating‘ or in patients after laryngectomy due 
to administration of mineral-oil containing pro-
ducts through the tracheostomy [3, 4, 6].
Table 1. Results of body plethysmography
Pred Pre %(Pre/Pred) Z-Score Pred LL Pred UL
FEV1% VC MAX (%) 78.27 81.22 104 0.45 67.56 88.98
FEV1% FVC (%) 78.27 85.00 109 1.03 67.56 88.98
VC MAX (L) 3.09 2.87 93 -0.48 2.36 3.85
FVC (L) 3.09 2.74 89 -0.77 2.36 3.85
FEV1 (L) 2.45 2.33 95 -0.35 1.87 3.01
MMEF 75–25 (L/s) 2.32 2.99 129 0.81 1.22 3.77
PEF (L/s) 5.93 9.20 155 3.64 4.44 7.41
R tot (kPA (L/s) 0.30 0.36 120 0.33 0.30
FRCpleth (L) 2.62 2.46 94 -0.32 1.80 3.44
RV (L) 1.79 1.56 87 -0.65 1.21 2.37
TLC (L) 4.70 4.44 94 -0.45 3.72 5.69
RV % TLC (%) 38.34 35.26 92 -0.53 28.75 47.93
DLCOc single breath 
[mmoL (min × kPa)]
6.53 4.74 73 -1.97 4.98 8.72
DLCOc_SB/VA [mmoL 
(min × kPa × L)]
1.45 1.15 79 -1.48 1.12 1.83
VIN single breath (L) 2.76 2.96 107 0.48 2.07 3.45
VA single breath (L) 4.55 4.12 91 -0.77 3.67 5.61
DLCOc — diffusion lung capacity for carbon monoxide corrected value; FEV1 — forced expiratory volume in 1 second; FRC — functional residual capacity; FVC — 
forced vital capacity; kPA — kilopascal; L — liter; LL — lower line; MMEF — maximal expiratory flow;min — minute;mmoL — milimoL; PEF — peak expiratory flow; 
Pre — present; Pred — predicted; R tot — total resistance; RV — residual volume; s — second; SB — single breath; TLC — total lung capacity; UL— upper line; 
VA — alveolar volume; VC — vital capacity; Vin — inspiratory volume
Table 2. Results of bronchoalveolar lavage
Probe volume 115 mL
Total cell count 25.7 (non-smokers/smokers: < 10 × 106 < 20 × 106) [× 106]
Cellular viability 82 [%]
macrophages 84.7 (non-smokers/smokers: > 80% > 90%) [%]
limphocytes 9.6 (non-smokers/smokers: < 15% < 10%) [%]
neutrophils 4.8 (non-smokers/smokers: < 3% < 3%) [%]
eozynophils 0.9 (non-smokers/smokers: < 0,5% < 0,5%) [%]
Probe description after MGG staining Significant amount of foamy macrophages, single amount of macrophages with small vacuole,  
single erythrocytes and epithelial cells
MGG — May-Grünwald Giemsa
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In our case report, we present an example of 
exogenous form of lipoid pneumonia, caused by 
chronic nasal drop use, in a patient with deviated 
nasal septum.  
In the presented woman, the first suggestion 
concerning the fatty-like character of pulmonary 
opacities came from chest CT description. Simi-
larly to our case, the most frequent radiologic 
manifestations described in the patients with 
lipoid pneumonia, are ground-glass opacities and 
consolidations involving one or more segments, 
typically with peribronchovascular distribution 
and predominant location in both lower lobes, 
with the adipose density (between -150 and -30 
HU), which can be found in 70–80% of patients 
[6, 8]. Other described forms are nodules and 
masses with irregular margins, which may be 
misdiagnosed as lung cancer [3, 6].
The confirmation of diagnosis, next to the 
radiological finding, may be achieved by demon-
stration of lipid-laden macrophages in BAL, in 
a patient with the history of lipid exposure. To 
verify the diagnosis, staining specific for lipids is 
often necessary [3, 6, 8, 9]. If the triad of history 
of mineral-oil ingestion, imaging finding and 
BAL finding are not decisive, transthoracic fine-
needle biopsy, transbronchial lung biopsy may 
be required. Surgical lung biopsy as the most 
invasive procedure should be reserved for the 
case of failure of other less invasive methods. 
Fine-needle biopsy or resection may be necessary 
if there is a risk of neoplasmatic process [2, 3, 6, 
8]. In the presented case, the patient’s history re-
vealed an over 10 years long exposure to paraffin 
oil-containing nasal drops, which in conjunction 
with CT scan findings and the presence of foamy 
macrophages in BAL, confirmed the diagnosis of 
exogenous lipoid pneumonia.
Essential for treatment of lipoid pneumonia is 
to identify and discontinue exposure. Other treat-
ments like steroids therapy or lung lavage are ba-
sed on other case reports and should be reserved 
for severe forms of disease. Lipoid pneumonia 
is commonly indolent and may regress without 
treatment [3, 6, 8]. However, in some cases, the 
radiological changes may be improving over time 
despite the discontinuation of exposure. Progres-
sion may lead to fibrosis and subsequently result 
in pulmonary hypertension [3].
Our patient was advised to stop using nasal 
drops. Due to normal lung function parameters, 
no further therapy was indicated. 
Conclusions
Lipoid pneumonia is an unusual cause of 
respiratory symptoms and can be either endo-
genous or exogenous. Clinical and radiological 
manifestations are diverse, therefore, in order 
to confirm the diagnosis of exogenous lipoid 
pneumonia, clinical history of lipid aspiration 
or inhalation, and proving the presence of lipid
-ladden macrophages in respiratory specimen 
are mandatory.
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